Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock

Shock

Volumn 5, Issue 6, 1996, Pages 391-394

  Szabó, Csaba ^a   Salzman, Andrew L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; GLIBENCLAMIDE; HEPARIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; TOLAZAMIDE; UK ATP 1 POTASSIUM CHANNEL; UK-ATP-1 POTASSIUM CHANNEL;

ANIMAL; ARTICLE; BLOOD PRESSURE; DISEASE MODEL; DRUG EFFECT; HEART RATE; HEMORRHAGIC SHOCK; MALE; PATHOPHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; GLYBURIDE; HEART RATE; HEPARIN; MALE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, WISTAR; SHOCK, HEMORRHAGIC; TOLAZAMIDE;

EID: 0030156687     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199606000-00001     Document Type: Article

References (18)

1. Nelson MT, Quayle JM: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268:C799-C822, 1995.
2. + channels. Science 247:1341-1343, 1990.
3. Miyoshi H, Nakaya Y, Moritoki H: Nonendothelial-derived nitric oxide activates the ATP-sensitive potassium channel of vascular smooth muscle cells. FEBS Lett 345:47-49, 1994.
4. Boyd AE, Aguilar-Bryan L, Nelson DA: Molecular mechanisms of action of glyburide on beta cell. Am J Med 89:3S-10S, 1990.
5. + channel mediates hypotension in endotoxemia and lactic acidosis in dog. J Clin Invest 89:2071-2074, 1992.
6. Vanelli G, Hussain SN, Aguggini G: Glibenclamide, a blocker of ATP-sensitive potassium channels, reverses endotoxin-induced hypotension in pig. Exp Physiol 80:167-170, 1995.
7. + channels in rats with cirrhosis. Gastroenterology 108: 1016-1023, 1994.
8. Szabó C, Salzman AL, Ischiropoulos H: Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett 372:229-232, 1995.
9. Zingarelli B, Squadrito F, Altavilla D, et al: Evidence for a role of nitric oxide in hypovolemic hemorrhagic shock. J Cardiovasc Pharmacol 19: 982-986, 1992.
10. Vromen A, Szabó C, Southan G, Salzman AL: Protective effects of isopropyl-isothiourea, a potent inhibitor of constitutive nitric oxide synthase in rodent and porcine models of hemorrhagic shock. J Appl Physiol 1996. In press.
11. 2 and liver blood flow following shock and ischemia. Prog Clin Biol Res 299:19-29, 1989.
12. Gardiner SM, Kemp P, March JE, Fallgren B, Bennett T: Effects of glibenclamide on the regional haemodynamic actions of alpha-trinositol and its influence on responses of vasodilators in conscious rats. Br J Pharmacol 117:507-515, 1996.
13. Wang X, Han CD, Fiscus RR, Qi M, Jones SB: Hypotension- and endotoxin-induced alterations in calcitonin gene-related peptide: Modulation by dexamethasone. Circ Shock 34:217-223, 1991.
14. Conlay LA, Evoniuk G, Wurtman RJ: Endogenous adenosine and hemorrhagic shock: Effects of caffeine administration or caffeine withdrawal. Proc Natl Acad Sci USA 85:4483-4485, 1988.
15. Szabó C, Thiemermann C: Role of nitric oxide in hemorrhagic, traumatic and anaphylactic shock and in thermal injury. Shock 2:145-155, 1994.
16. Zellweger R, Ayala A, Zhu XL, Holme KR, DeMaso CM, Chaudry IH: A novel nonanticoagulant heparin improves splenocyte and peritoneal macrophage immune function after trauma-hemorrhage and resuscitation. J Surg Res 59:211-218, 1995.
17. Wang P, Ba ZF, Chaudry IH: Chemically modified heparin improves hepatocellular function, cardiac output, and microcirculation after trauma-hemorrhage and resuscitation. Surgery 116:169-175, 1994.
18. Stern SA, Dronen SC, Birrer P, Wang X: Effect of blood pressure on hemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury. Ann Emerg Med 22:155-163, 1993.